Sr. Manager, New Product Planning

CSL Behring
Summit, New Jersey
Jul 10, 2021
Pharm Country
Required Education
Bachelors Degree
Position Type
Full time

With operations in 35+ nations and ~27,000 employees worldwide, CSL is driven to develop and deliver a broad range of lifesaving therapies to treat disorders such as hemophilia and primary immune deficiencies, and vaccines to prevent influenza. Our therapies are also used in cardiac surgery, organ transplantation and burn treatment.

CSL is the parent company of CSL Behring and Seqirus. CSL Behring is a global leader in the protein biotherapeutics industry, focused on bringing to market biotherapies used to treat serious and often rare conditions. CSL Behring operates CSL Plasma, one of the world's largest collectors of human plasma, which is used to create CSL’s therapies. Seqirus is one of the largest influenza vaccine companies in the world and is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally.

We invite you to take a look at the many career possibilities available around the globe and consider building your promising future at CSL by becoming a member of our team!

Job Description

Job Summary:

The Senior Manager, New Product Development is involved in early commercialization activities within the Franchise Strategy & Market Access team including new product planning, new product and opportunity assessments, and development and evolution of go-to-market strategies. Working with the Director of Strategy & New Products, the Senior Manager’s primary responsibilities include supporting the build and execution of early commercialization plan / go-to-market strategy for assets in Phase 2 of clinical development and beyond, and developing market and commercial assessments to support new product planning and investment decisions.     

Major Responsibilities:

Strategic New Product Planning: Mid-to-late stage assets

  • Working with senior management, support the creation, evolution, and facilitation of new products equivalent of “Global Brand Strategy Team” for assets in Phase 2 through Phase 3 (at which point assets may transition from new products team to launch/brand team)
  • Lead significant collaboration with internal and external partners particularly Medical Affairs, Health Economics, Clinical & Regulatory as well as outside agencies to translate relevant clinical and economic trends into commercial strategies
  • Lead and execute life cycle planning, assessment of potential portfolio positioning, and prioritization of launch markets
  • Monitor short and long-term market trends that impact new product and continuously identify opportunities and gaps to feed into the Early Commercialization / Go-to-Market Plan
  • Drive appropriate market research or advisory boards to close knowledge gaps, inform strategic direction, anticipate customer needs and take action to meet them in advance
  • Participation within new products equivalent of Global Brand Strategy Team(s)
  • Participation in annual strategic planning processes, Long Range Planning, Early Commercialization / Go-to-Market Planning, and Integrated Franchise Planning (for flu portfolio related assets)

Strategic New Product Planning: Early phase assets

  • Works with colleagues in R&D, Business Development, Commercial, Strategy to build business cases to support new product investment decisions
  • Responsible for providing market research and analytical support to interpret key business and market dynamics
  • Partners across commercial and other functions to proactively recommend, develop, and implement market research plans that address new product design and opportunity questions
  • Organizes information to assist in analysing future products and makes recommendations for the development of new products
  • Provides decision and executional support for commercial assessments, product forecasting, new product / brand planning, strategic planning, data modelling, scenario analysis and other planning efforts
  • Presents detailed analysis and insights in a manner that is easily interpreted and aids strategic and tactical decision making
  • Keeps abreast of new methodologies to ensure research performed is cost effective and provides optimal results
  • Participation within CPT(s)
  • Participation in annual strategic planning processes, Long Range Planning, Early Commercialization / Go-to-Market Planning, and Integrated Franchise Planning (for flu portfolio related assets)

Strategic Growth Opportunity Evaluation

  • Working with senior leadership and in collaboration with R&D and BD, supports design and facilitation of cross-functional new products and innovation workshops to assess external areas of opportunities for growth (adjacencies, new therapy areas, etc.)
  • Supports development of market landscape evaluations, market sizing and growth, competitor assessments, revenue and commercial cost structure forecasts, and other content to inform cross-functional and senior leadership innovation/growth workshops and due diligence activities for external asset evaluation

Minimum Qualifications:
  • Bachelor’s Degree required, preferably in Life Science, Business/Marketing, or related field. MBA or other advanced degree preferred.
  • At least 7 years working experience in the pharmaceutical, devices, or other health care industry
  • Demonstrated strategic thinking, analytics, and effective project management skills
  • Demonstrated self-starter with experience working in multi-functional teams  
  • Experience in leading a multi-functional team within an indirect reporting structure
  • Top tier healthcare consulting experience a plus
  • Vaccines experience a plus